Wednesday, 12 Dec 2018

You are here

RheumNow Week in Review – 22 April 2016

Highlights from this week on RheumNow.com

  1. Systematic review by Felson et al shows that MTX use in current RA clinical trials is suboptimal, most using 15mg, the highest dose was 20mg/wk and only one trial with parenteral MTX.  https://t.co/1DYHxLK2DJ
  2. There's a despirate need for effective DMARD or biologic therapy for patients with with erosive osteoarthritis! GSK announced the launch of its Phase 2 trial of GM-CSF MAb in patients with inflammatory hand OA. https://t.co/cXNdTDufR7
  3. Celltrion chief executive said that Inflectra is expected to be priced ~20-30% lower than Remicade when released in the US. https://t.co/ceCHuYubzK
  4. Perioperative MTX use does not cause increased postoperative infectious complications or sepsis in IBD patients having abdominal surgery. https://t.co/ApgCyEhpeG
  5. A New Look at Old Pictures.  Dr. David Pisetsky blogs on the appropriate or misleading use of picture to educate. 
  6. Do's and Don'ts of Vaccination: a (Very) Brief Guide for Rheumatologists by Dr. Kevin Winthrop.  
  7. Vaccine Success is Limited in Rheumatoid Arthritis.  
  8. α Defensin Control of Inflammation.  The protective effects of defensins and their therapeutic potential is proposed.  
  9. BeST Trial and 10-Year Outcomes of Four Treatment Strategies
  10. Osteoporotic Fractures at Higher Risk for Subsequent Fractures  

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

RheumNow Podcast – Can RA Be Prevented (12.7.18)

Dr. Jack Cush reviews the news and new journal articles from the past week on RheumNow.com:

Chronic Kidney Disease Increasing in the U.S.A.

JAMA has published the Global Burden of Disease (GBD) study showing that that, from 2002 to 2016, the US burden of chronic kidney disease (CKD) increased, with some states exhibiting more than twice the burden as others. The increase in burden was associated with increased metabolic and dietary risk exposure that manifested in increased probability of death due to diabetic CKD, especially for those between 20 to 55 years.  

RheumNow Podcast – To Needle or Not to Needle (11.30.18)

Dr. Jack Cush updates the news and reports from the past week at RheumNow.com:

Physical Activity Guidelines for Americans

The data are clear and disappointing: despite the well-known health benefits, four out of five US adults are not active physically.  JAMA has published the new US Physical Activity Guidelines for Americans, so that health professionals and policy makers can promote lifestyle changes and awareness of the the health benefits of physical activity.

The RheumNow Podcast – Heartbreak of Methotrexate (11.16.18)

Dr. Jack Cush reviews the news from the past week at RheumNow.com.